Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOOST KIDNEY: Pfizer vs Moderna Boosters in CKD
NCT05022329Phase 3Terminated
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Sep 2021
- Primary completion
- May 2022
- Modality
- Vaccines & Immunotherapeutics, Lipid-based Nanoparticles, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of tozinameran, elasomeran in coronavirus disease 2019 (COVID-19), sponsored by Sunnybrook Health Sciences Centre. Started Sep 2021; status: terminated.
02
Drugs
tozinameranelasomeran
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05022329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05022329.